Antigen loss and tumor-mediated immunosuppression facilitate tumor recurrence

Expert Review of Vaccines

Volumn 11, Issue 11, 2012, Pages 1315-1317

  Olson, Brian m ^a   McNeel, Douglas g ^a  

^a UNIVERSITY OF WISCONSIN   (United States)

Author keywords

adoptive transfer; antigen loss variant; immunotherapy; tumor escape variant; tumor immunosuppression

Indexed keywords

EID: 84879404951     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.12.107     Document Type: Article

References (8)

1. Jensen SM, Twitty CG, Maston LD et al. Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrence. J. Immunol. 189 (2), 767 – 776 (2012).
2. Khong HT, Restifo NP. Natural selection of tumor variants in the generation of ‘tumor escape’ phenotypes. Nat. Immunol. 3 (11), 999 – 1005 (2002).
3. Ahmad M, Rees RC, Ali SA. Escape from immunotherapy: possible mechanisms that influence tumor regression/progression. Cancer Immunol. Immunother. 53 (10), 844 – 854 (2004).
4. Hu HM, Poehlein CH, Urba WJ, Fox BA. Development of antitumor immune responses in reconstituted lymphopenic hosts. Cancer Res. 62 (14), 3914 – 3919 (2002).
5. Shankaran V, Ikeda H, Bruce AT et al. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410 (6832), 1107 – 1111 (2001).
6. DuPage M, Mazumdar C, Schmidt LM, Cheung AF, Jacks T. Expression of tumour-specific antigens underlies cancer immunoediting. Nature 482 (7385), 405 – 409 (2012).
7. Zhou G, Lu Z, McCadden JD, Levitsky HI, Marson AL. Reciprocal changes in tumor antigenicity and antigen-specific T cell function during tumor progression. J. Exp. Med. 200 (12), 1581 – 1592 (2004).
8. Dudley ME, Wunderlich JR, Robbins PF et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298 (5594), 850 – 854 (2002).